e s f letters
e s f letters
bioprocessing conference

Central New York Biotechnology Symposium 2011

Agenda: Some Powerpoints have been posted with the author's approval.

(Please note: Power point material is for personal reference only and not for distribution in any way or form without permission from the author.)

Thursday, June 2, 2011

5-7 p.m.

Networking Reception and Poster Session, moderated by Dr. Dacheng Ren, Assistant Professor, Dept of Biomedical and Chemical Engineering, Syracuse University

Friday, June 3, 2011

7:15 a.m. Registration and continental breakfast

Conference Welcome

Dr. John Fieschko, Program Chair and Executive Director, CNY Biotechnology Research Center


Keynote Speaker: Cultivating Economic Growth in Central New York

Joanne M. Mahoney, Onondaga County Executive

Ed Reinfurt, Director, Division of Science, Technology & Innovation, Empire State Development (PPT)

  Uses of Biotechnology to Improve Health Care Improving the Environment Through Applications of Biotechnology

Drug Discovery and Development

Dr. Charles Montgomery, Section Head, AMRI (PPT)

Dr. Ziwei Huang, Director, the Upstate Cancer Research Institute, Professor and Chairman, Department of Pharmacology, SUNY Upstate Medical University (PPT)

Bioremediation and Environmental Clean Up

Dr. Lee Newman, Assistant Professor, Dept of Environmental and Forest Biology, SUNY-ESF

Mr. Michael Kozar, O'Brien & Gere (PPT)

10:00 Break to visit tabletops and posters

Starting Your Own Biotechnology Company in Central New York: Legal, Business and Funding Issues

Moderator: Richard Engel, Attorney, MacKenzie Hughes LLP

Dr. Brian Meltzer, Business Leader - Therapeutic Decisions & Clinical Innovations, Johnson & Johnson

Dr. John Liddy, Entrepreneur in Residence, Lemoyne College (PPT)

Ms. Linda Dickerson Hartsock, Vice President of Innovation & Technology Initiatives and Director of Clean Technology Initiatives, The Technology Garden (PPT)


Lunch Presentations

Central New York Biotechnology Research Center Building Design, the S.L.A.M. Collaborative

Central New York Biotechnology Research Center Design Operating Parameters, Dr. John C. Fieschko, Executive Director, CNY BRC

Poster Session Award Ceremony, Dr. Dacheng Ren, Syracuse University

1:00 p.m. Break to visit tabletops and posters

Patient Specific Cell Therapies

Dr. Christopher Choi, Director of Therapeutic Cell Production Facility, Roswell Park Cancer Institute (PPT)

Dr. Carmelo Gaudioso, Director of Medical Informatics and Clinical Data Network, Roswell Park Cancer Institute (PPT)

Mr. Donald Handley, Administrative Director of Research Subject Protection, Roswell Park Cancer Institute (PPT)

Dr. Michael Sinclair, Co-President and Laboratory Director, Microcheck Microbial Analysis Laboratory (PPT)

Agricultural Applications of Biotechnology

Moderator: Dr. Surabhi Raina, Assistant Professor, Dept of Biology, Syracuse University

Ms. Jennifer Crisp, Esquire, Assistant Director, Office of Technology Transfer & Industrial Development, Syracuse University

Dr. Daniel van der Lelie, Senior Director, Research Triangle Institute International

Dr. Frank A. Shotkoski, Director Agricultural Biotechnology Support Project, Cornell University (PPT)



Trends in Biopharmaceutical Manufacturing: Flexibility and Use of Disposables

Moderator: Dr. Kirk Leister, Director of Process Analytical Sciences and Technical Operations, Bristol-Myers Squibb

Dr. Michael Hausladen, Director of Manufacturing Pilot Plant, at Bristol-Myers Squibb (PPT)

Mr. Dan Bauer, Commercial Executive, FlexFactoryTM Facilities, Xcellerex, Inc. (PPT)

Mr. Steven Moore, Business Development Manager, GE Healthcare-Life Sciences (Abstract)

Bioproducts and Bioenergy Production

Moderator: Dr. Jim Nakas, Professor, Dept of Environmental and Forest Biology, SUNY-ESF

Mr. Doug DiLillo, Industrial Biotechnology Market Lead, Pall Corporation (PPT)

Mr. Joe Dickson, COO/CFO, e2e Materials (PPT)

Mr. Joseph Holroyd, Vice President and COO, LakeMaster Corporation (PPT)

Mr. Chris Gidopoulos, Sr. Director of Corporate Development, Myriant Technologies, Inc. (PPT)

3:45 Program Concludes